Founded in 2003, Nanhai Longtime Pharmaceutical Co., Ltd. is the industrialization base of the national first-class new drug “ recombinant human basic fibroblast growth factor（rh-bFGF）”. rh-bFGF is clinically used for the treatment of trauma, surgical wounds, burns and ulcers, etc., producing significant therapeutic effects. It is a first-line medication recommended by Clinical Guideline. Over the years, it has won many national awards, such as the Second Prize of National Award for Technological Invention and the First Prize of National Science and Technology Progress Award.